Investigation of β-hydroxybutyrate Supplementation as Chemoprevention in Familial Adenomatous Polyposis
Clinical trial NCT06578637 · RECRUITING
Trial details
- NCT number
- NCT06578637
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-20
- Primary completion
- 2027-10-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.